Wiener Privatklinik
Wiener Privatklinik
Austria, Vienna
Christoph Zielinski
44 years of experience
accreditations :
Clinic is certified :
Liver cancer stage 2 treatment cost in Austria typically includes essential diagnostics such as a consultation with an oncologist, which ranges from $200 to $400. Primary therapeutic interventions like chemotherapy for breast cancer run from $15,000 to $25,000, while radiation therapy for colorectal cancer costs $12,000 to $18,000. Total expenses depend on the tumor size, surgical complexity, and choice between private or university hospitals. Patients often find 20-30% savings compared to the US. Most specialized care is concentrated in Vienna.
Typical Liver Cancer Stage 2 Treatment Costs in Austria
Bookimed Expert Insight: Patients seeking high-level academic expertise should consider Wiener Privatklinik. It features professors from the Medical University of Vienna. For complex cases, Univ. Prof. Dr. Christoph Zielinski provides world-class immunotherapy protocols. This clinic is recognized by Newsweek as one of the World's Best Hospitals. Döbling Private Hospital is ideal for those prioritizing safety. It maintains complication rates significantly below national averages. Both facilities offer personalized care in a multilingual environment. This ensures international patients receive coordinated, high-tier oncological treatment.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
Prof. Zielinski leads Wiener Privatklinik's International Oncology Center, specializing in personalized cancer medicine and immunotherapy.
Univ. Prof. Dr. Wolfgang Köstler is a distinguished medical oncologist who helped pioneer targeted therapies – a core strategy for treating many liver cancers today.
Dr. Arnulf Ferlitsch is a specialist in internal medicine, gastroenterology, and hepatology. He completed his medical studies in Vienna in 1998. He continued his training at top institutions, including UCLA and the University of Pennsylvania. From 2000 to 2010, he focused on internal medicine, gastroenterology, hepatology, and intensive care.
Dr. Ferlitsch has received several research awards, such as the UEGW Best Abstract Award (2003, 2005, 2008, 2009, 2010, 2012), the Ferring Prize, and the Skoda Prize. He founded the hepatic hemodynamics laboratory and the liver cirrhosis outpatient clinic at the Medical University of Vienna. Since 2018, he has led the Department of Internal Medicine I at the Hospital of the Barmherzigen Brüder in Vienna.